Global Urinary Incontinence Market by Cover Page

Urinary Incontinence Market

  • HC-4136
  • 4.3 Rating
  • 188 Pages
  • Upcoming
  • 74 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

The global urinary incontinence market size was valued at USD 10.9 billion in 2021 and is expected to surpass USD 19.1 billion by 2030, expanding at a CAGR of 6.5% during the forecast period, 2022–2030. The growth of the market is attributed to the wide prevalence of the disorder among the geriatric population and rising spending on the disorder treatment.
 

Global Urinary Incontinence Market by Summary

Urinary incontinence is a condition of an involuntary urine leakage primarily caused by a broken sphincter or a malfunctioning bladder. The disorder is also known as an overactive bladder as it is closely associated with people having bladder control issues due to weakness of bladder muscles or nerves. Urine leaking problem is most commonly occurred among the older people, especially women and the problem may arise even on exerting some pressure on the bladder due to laughing, coughing, sneezing, or light physical exercises. To women, the cause of the disorder may vary and can happen due to certain and unique body functions such as pregnancy, childbirth, and menopause, which results in weakening muscles and nerves around the bladder. However, being overweight can be a key factor in causing the disorder for both men and women. The severity level of the disorder may differ from one person to another depending on the types of causes, types of the disorder, and age factors. Using appropriate treatment methods, most of urinary incontinence cases can be controlled and even cured. Several devices are available for the treatment and the devices can assist patients for effective management of the disorder.

The COVID-19 pandemic had posed a threat to the market expansion as almost all medical and healthcare institutions including hospitals and clinics have focused on tackling the emerging healthcare burden of coronavirus cases. Patients with urinary incontinence preferred to continue home treatment and avoid visiting hospitals to avoid the risks of the virus spreading. As per several global reports, the number of patients having outpatient tests and treatments and demand for surgical treatment for various kidney and bladder stones had substantially declined during the pandemic.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising geriatric population and wide occurrence of urinary disorders among the women population globally are key factors driving the market.
  • Rapid development of advanced devices for urinary incontinence treatment and rising demand for minimally invasive operations among patients present other key drivers of the market.
  • Growing awareness regarding the effective treatment methods for the disorder and increasing healthcare spending are expected to boost the market during the forecast period.
  • Lack of awareness of effective treatment methods and continuation of traditional treatment methods act as major hurdles that can hamper the market.
  • Technological advancements for the development of innovative treatment devices and user-friendly disposable products are likely to create several growth opportunities for the market.

Scope of the Report

The report on the global urinary incontinence market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Urinary Incontinence Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2019–2020

Forecast Period

2022–2030

Segmentation

Types (Urge Urinary Incontinence, Functional Urinary Incontinence, Stress Urinary Incontinence, and Overflow Urinary Incontinence), Products (Devices and Disposables), and End-users (Home Care, Hospitals & Clinics, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation.

 

Market Segment Insights

Stress urinary incontinence segment holds a dominant market share

Based on types, the global urinary incontinence market is divided into urge urinary incontinence, functional urinary incontinence, stress urinary incontinence, and overflow urinary incontinence. The stress urinary incontinence (SUI) segment held a dominant market share in 2021 and is expected to expand at a rapid pace during the forecast period owing to rising incidences of the urinary incontinence type among a large number of the women population worldwide. As per global reports, around 50% of women having urinary incontinence disorder are likely to experience SUI.

Higher rate of disposables consumption drives the disposables segment

In terms of products, the market is bifurcated into devices and disposables. The disposables segment is anticipated to hold a key share of the market in the coming years due to a higher rate of disposables consumption among patients and the availability of low-price disposable treatment products. On the other hand, the devices segment is anticipated to register a robust growth rate in the coming years due to rising spending on advanced device treatment methods due to high rate of treatment success.
 

Global Urinary Incontinence Market by Products

High admission rate of the patients boosts the hospitals & clinics segment

On the basis of end-users, the global urinary incontinence market is segregated into home care, hospitals & clinics, and others. The hospitals & clinics segment constituted a dominant market share in 2021 and is projected to register a considerable CAGR during the forecast period due to high admission rate of the patients to hospitals and frequent patient visits to hospitals for treatment. The presence of various specialized medical staff and technicians for the diagnosis and treatment of the disorders along with the availability of advanced treatment devices in hospitals and clinics further boost the segment.

North America is anticipated to constitute a key market share

In terms of regions, the global urinary incontinence market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the projected period owing to the presence of a wide pool of geriatric population and rising cases of urinary incontinence in the region. The early adoption of novel devices for the treatment of the disorder and rising spending in the healthcare sector present other key drivers of the regional market. On the other hand, the Asia Pacific market is anticipated to expand at a rapid pace during the forecast period owing to increasing awareness about the advanced treatment methods for the disorder and rising healthcare expenditure among a large portion of the population in the region.
 

Global Urinary Incontinence Market by Regions

Segments

Segments Covered in the Report

The global urinary incontinence market has been segmented on the basis of

Types

  • Urge Urinary Incontinence
  • Functional Urinary Incontinence
  • Stress Urinary Incontinence
  • Overflow Urinary Incontinence

Products

  • Devices
  • Disposables

End-users

  • Home Care
  • Hospitals & Clinics
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Medtronic plc
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Caldera Medical
  • Coloplast A/S
  • ConvaTec Group plc
  • Cook Group Inc.
  • Johnson and Johnson
  • Laborie Medical
  • Asahi Kasei Corporation
  • Georgia-Pacific LLC
  • Kimberly-Clark Corporation
  • Berry Global Inc.
  • First Quality Enterprises, Inc.
  • Freudenberg & Co. KG
  • Unicharm Corporation
  • Ahlstrom-Munksjo 
  • Domtar Corporation

Competitive Landscape

Key players competing in the global urinary incontinence market are Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; Johnson and Johnson; Laborie Medical; Asahi Kasei Corporation; Georgia-Pacific LLC; Kimberly-Clark Corporation; Berry Global Inc.; First Quality Enterprises, Inc.; Freudenberg & Co. KG; Unicharm Corporation; Ahlstrom-Munksjo; and Domtar Corporation.
 

Global Urinary Incontinence Market by Key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Urinary Incontinence Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Urinary Incontinence Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Urinary Incontinence Market - Supply Chain
  4.5. Global Urinary Incontinence Market Forecast
     4.5.1. Urinary Incontinence Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Urinary Incontinence Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Urinary Incontinence Market Absolute $ Opportunity
5. Global Urinary Incontinence Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Urinary Incontinence Market Size and Volume Forecast by Types
     5.3.1. Urge Urinary Incontinence
     5.3.2. Functional Urinary Incontinence
     5.3.3. Stress Urinary Incontinence
     5.3.4. Overflow Urinary Incontinence
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Urinary Incontinence Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Urinary Incontinence Market Size and Volume Forecast by End Users
     6.3.1. Home Care
     6.3.2. Hospitals & Clinics
     6.3.3. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Urinary Incontinence Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Urinary Incontinence Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Urinary Incontinence Demand Share Forecast, 2019-2026
8. North America Urinary Incontinence Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Urinary Incontinence Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Urinary Incontinence Market Size and Volume Forecast by Types
     8.4.1. Urge Urinary Incontinence
     8.4.2. Functional Urinary Incontinence
     8.4.3. Stress Urinary Incontinence
     8.4.4. Overflow Urinary Incontinence
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Urinary Incontinence Market Size and Volume Forecast by End Users
     8.7.1. Home Care
     8.7.2. Hospitals & Clinics
     8.7.3. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Urinary Incontinence Demand Share Forecast, 2019-2026
9. Latin America Urinary Incontinence Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Urinary Incontinence Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Urinary Incontinence Market Size and Volume Forecast by Types
     9.4.1. Urge Urinary Incontinence
     9.4.2. Functional Urinary Incontinence
     9.4.3. Stress Urinary Incontinence
     9.4.4. Overflow Urinary Incontinence
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Urinary Incontinence Market Size and Volume Forecast by End Users
     9.7.1. Home Care
     9.7.2. Hospitals & Clinics
     9.7.3. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Urinary Incontinence Demand Share Forecast, 2019-2026
10. Europe Urinary Incontinence Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Urinary Incontinence Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Urinary Incontinence Market Size and Volume Forecast by Types
     10.4.1. Urge Urinary Incontinence
     10.4.2. Functional Urinary Incontinence
     10.4.3. Stress Urinary Incontinence
     10.4.4. Overflow Urinary Incontinence
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Urinary Incontinence Market Size and Volume Forecast by End Users
     10.7.1. Home Care
     10.7.2. Hospitals & Clinics
     10.7.3. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Urinary Incontinence Demand Share Forecast, 2019-2026
11. Asia Pacific Urinary Incontinence Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by Types
     11.4.1. Urge Urinary Incontinence
     11.4.2. Functional Urinary Incontinence
     11.4.3. Stress Urinary Incontinence
     11.4.4. Overflow Urinary Incontinence
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Urinary Incontinence Market Size and Volume Forecast by End Users
     11.7.1. Home Care
     11.7.2. Hospitals & Clinics
     11.7.3. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Urinary Incontinence Demand Share Forecast, 2019-2026
12. Middle East & Africa Urinary Incontinence Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by Types
     12.4.1. Urge Urinary Incontinence
     12.4.2. Functional Urinary Incontinence
     12.4.3. Stress Urinary Incontinence
     12.4.4. Overflow Urinary Incontinence
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Urinary Incontinence Market Size and Volume Forecast by End Users
     12.7.1. Home Care
     12.7.2. Hospitals & Clinics
     12.7.3. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Urinary Incontinence Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Urinary Incontinence Market: Market Share Analysis
  13.2. Urinary Incontinence Distributors and Customers
  13.3. Urinary Incontinence Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Boston Scientific Corporation
     13.4.2. Cardinal Health, Inc.
     13.4.3. Medtronic plc
     13.4.4. Becton, Dickinson and Company
     13.4.5. Teleflex Incorporated
     13.4.6. Caldera Medical
     13.4.7. Coloplast A/S
     13.4.8. ConvaTec Group p

Purchase Premium Report

FAQ Section

Some frequently asked questions about this report!

Key players of the market are Boston Scientific Corporation; Cardinal Health, Inc.; Medtronic plc; Becton, Dickinson and Company; Teleflex Incorporated; Caldera Medical; Coloplast A/S; ConvaTec Group plc; Cook Group Inc.; and Johnson and Johnson.

North America is expected to account for a key share of the market during the projected period.

The stress urinary incontinence (SUI) segment held a dominant market share in 2021 and is expected to constitute a key share of the market during the forecast period.

Key players of the market include the wide prevalence of the disorder among the geriatric population and rising spending on the disorder treatment.

The global urinary incontinence market size was valued at USD 10.9 billion in 2021 and is expected to surpass USD 19.1 billion by 2030.